Stock research firms currently have a positive stance on shares of Glu Mobile Inc. (NASDAQ:GLUU). Analysts are projecting that the stock will reach $3.28 on a short term (1 year) basis.
The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.30. This is based on the research brokerage reports taken into consideration by Thomson Reuters.
At the time of writing, the stock was trading at $3.76. This represents a change from most recent open price of 4.02%. In terms of performance, year to date, the stock is 85.05%. The monthly stock performance comes in at 2.28%. For the quarter, shares are performing at 40.78%. Weekly performance analysis shows the equity at -4.77%.
In taking a look at technical levels, shares are trading 9.34% away from the 50 day simple moving average and 43.01% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -1.96% away from it’s 52- week high and 117.05% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Glu Mobile Inc.’s RSI stands at 58.85. In looking at volatility levels, the shares saw weekly volatility of 3.31% and 3.47% over the past month.
Brokerage firms currently have a positive stance on shares of Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. Those same analysts are projecting that the stock will reach $5.10 on a short term basis.
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) shares typically trade an average volume of 1020.70 and institutions hold 38.00% of the total shares.
We see here that the stock is 12.28% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of 45.53% from current levels. Further back, their 200-Day Simple Moving Average is 32.96% difference from today’s price. Currently, the stock is -37.74% from its 50-Day High and 113.95% from the 50-day low.
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB)‘s stock has performed at -37.67%. Breaking that down further, it has performed -20.49% for the week, 55.17% for the month, 82.93% over the last quarter, 57.34% for the past half-year and -56.98% for this last year.